Rxi Pharmaceuticals Obtains Partnership Agreement For ALS With Thera Neuropharma
May 03, 2016 at 11:43 AM EDT
The license agreement expands on the notion that Thera NeuroPharma will use Rxi's sd-rxRNA technology platform to develop neurodegenerative disease medicines.
